← Open Payments lookup

SHARON MCLEMORE: Open Payments

NPI 1750616801 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$384 in 17 payments from 8 companies in 2025. Trend: 2023 $64 · 2024 $57 · 2025 $384

Food & beverage: $384
CompanyPaymentsAmount
Sumitomo Pharma America, Inc.7$178
Corcept Therapeutics4$114
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
Inspire Medical Systems, Inc.1$17
Supernus Pharmaceuticals, Inc.1$15
Novo Nordisk Inc1$15
Antares Pharma, Inc.1$14
Lilly USA, LLC1$14

Products named: GEMTESA, Korlym, CAPLYTA, INSPIRE, Qelbree, Ozempic, XYOSTED.

Industry payments across TX — which companies pay providers there.